Skip to content

Short-Term Clinical Comparison of Two Silicone Hydrogel Daily Disposable Contact Lenses

Short-Term Clinical Comparison of Two Silicone Hydrogel Daily Disposable Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03139578
Enrollment
51
Registered
2017-05-04
Start date
2017-04-28
Completion date
2017-10-22
Last updated
2019-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual Acuity

Brief summary

This will be a 2 period one-day, double-masked, randomized, repeated measures, non-dispensing, cross-over study where the main purpose of this study is to compare the performance of a new daily disposable silicone hydrogel lens with that of an existing similar lens.

Interventions

DEVICETest 8.5BC

senofilcon A contact lenses with 8.5 base curve

DEVICETest 9.0BC

senofilcon A contact lenses with 9.0 base curve

DEVICEControl 8.5BC

narafilcon A contact lenses with 8.5 base curve

DEVICEControl 9.0BC

narafilcon A contact lenses with 9.0 base curve

Sponsors

Johnson & Johnson Vision Care, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

Both the investigator and the subjects are masked to the identity of the study lenses. Lenses were over-labelled and coded to mask the lens foil. Over-labelling was carried out by the study sponsor following specific SOPs (see ICH GCP guidelines Section 5.13).

Intervention model description

Contra-lateral Assignment

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

Potential subjects must satisfy all of the following criteria to be enrolled in the study: 1. The subject must read and sign the Informed Consent form. 2. The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol. 3. Healthy adult males or females aged 18-55 years. 4. The subject's spherical contact lens requirement in the range +2.00 D to +4.00 D or -1.00 D to -6.00 D. 5. The subject's refractive cylinder must be ≤1.00 D in each eye. 6. The subject must have visual acuity best correctable to 6/9 (20/30) or better for each eye. 7. The subject is a current soft contact lens wearer (defined as a minimum of 6 hours of DW per day, at least 5 days per week, for a minimum of 1 month prior to the study). 8. The subject must have normal eyes (i.e., no ocular medications or infections of any type).

Exclusion criteria

Potential subjects who meet any of the following criteria will be excluded from participating in the study: 1. Currently pregnant or lactating 2. Any systemic disease (e.g., Sjögren's Syndrome),allergies, infectious disease (e.g., hepatitis,tuberculosis), contagious immunosuppressive diseases (e.g., HIV), autoimmune disease (e.g. rheumatoid arthritis), or other diseases, by self-report, which are known to interfere with contact lens wear and/or participation in the study. 3. Use of systemic medications (e.g., chronic steroid use) that are known to interfere with contact lens wear. 4. Any ocular allergies, infections or other ocular abnormalities that are known to interfere with contact lens wear and/or participation in the study. This may include, but not be limited to entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, aphakia, or corneal distortion. 5. Extended wear contact lens correction. 6. Any current use of ocular medication. 7. Any previous, or planned (during the course of the study) ocular surgery (e.g., radial keratotomy, PRK, LASIK, etc.) 8. Any greater than Grade 2 slit lamp findings (e.g., oedema, corneal neovascularisation, corneal staining, tarsal abnormalities, conjunctival injection) on the FDA classification scale or any other ocular abnormality that may contraindicate contact lens wear. 9. Any contact lens-related history or signs of a corneal inflammatory event, or any other ocular abnormality that would contraindicate contact lens wear. 10. Participation in any contact lens or lens care product clinical trial within 14 days prior to study enrolment. 11. Employee, relative or friends of employees of any ophthalmic company, or investigational clinic (e.g., Investigator, Coordinator, Technician).

Design outcomes

Primary

MeasureTime frameDescription
Overall Fit Acceptance30-45 minutes after lens settlingOverall lens fit acceptance was assessed by the investigator based on lens fitting characteristics and graded on a scale of 0 to 5, where 0=should not be worn and 5=perfect fit. The score ranges from 0 to 5, where higher scores indicate better fitting. The number of eye for each Grade was reported.
Lens Power Requirement30-45 minutes after lens settlingThe lens power requirements (aka sphere requirements) for each lens type was calculated by summing the lens power and the spherical over-refraction. Then the difference of lens power requirement between the Test and Control lenses was calculated (Test-Control).

Secondary

MeasureTime frameDescription
Subjective Vision Quality30-45 minutes after lens settlingSubjective vision quality was assessed by the subject on an 11-point scale (0 to 10) where 0=extremely blurred and 10=perfect. The score ranges from 0 to 10, where higher scores indicate better vision quality. The average vision quality score for each lens was reported.
Subjective Comfort at Lens InsertionImmediately upon lens insertionSubjective comfort on insertion was assessed by the subject on an 11-point scale (0 to 10) where 0=painful and 10=can't be felt. The score ranges from 0 to 10, where higher scores indicate better comfort. The average comfort score for each lens was reported.
Monocular High Contrast Visual Acuity (VA)30-45 minutes after lens settlingMonocular high contrast distance VA with the study lenses was collected to the nearest letter using computer generated logMAR charts. 0.02 logMAR is equivalent to 1 letter. Negative logMAR values indicate better lens performance. The average visual acuity was reported for each lens type.
Subjective HandlingImmediately upon lens insertionSubjective handling was assessed by the subject on an 11-point scale (0 to 10) where 0=extremely difficult and 10=very easy. The score ranges from 0 to 10, where higher scores indicate better handling. The average handling score for each lens was reported.
Subjective Comfort After Lens Settling30-45 minutes after lens settlingSubjective comfort on setting was assessed by the subject on an 11-point scale (0 to 10) where 0=painful and 10=can't be felt. The score ranges from 0 to 10, where higher scores indicate better comfort. The average comfort score for each lens was reported.

Countries

United Kingdom

Participant flow

Recruitment details

A total of 51 subjects were enrolled in the study from two sites. Of those enrolled, 50 subjects were randomized and 50 subjects were dispensed a study lens. All 50 subjects completed the study, while no one discontinued from the study.

Baseline characteristics

CharacteristicTotal
Age, Continuous30.3 years
STANDARD_DEVIATION 13.61
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
47 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
14 Participants
Race (NIH/OMB)
Black or African American
3 Participants
Race (NIH/OMB)
More than one race
13 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
20 Participants
Region of Enrollment
United Kingdom
50 Participants
Sex: Female, Male
Female
34 Participants
Sex: Female, Male
Male
16 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 500 / 500 / 500 / 50
other
Total, other adverse events
0 / 500 / 500 / 500 / 50
serious
Total, serious adverse events
0 / 500 / 500 / 500 / 50

Outcome results

Primary

Lens Power Requirement

The lens power requirements (aka sphere requirements) for each lens type was calculated by summing the lens power and the spherical over-refraction. Then the difference of lens power requirement between the Test and Control lenses was calculated (Test-Control).

Time frame: 30-45 minutes after lens settling

Population: All subjects who had successfully completed all required assessments without a major protocol deviation.

ArmMeasureCategoryValue (COUNT_OF_UNITS)
Test 8.5BCLens Power Requirement-2.00 t -1.509 Eyes
Test 8.5BCLens Power Requirement<= -3.7510 Eyes
Test 8.5BCLens Power Requirement-1.25 to -0.752 Eyes
Test 8.5BCLens Power Requirement>= -0.503 Eyes
Test 8.5BCLens Power Requirement-3.50 to -3.007 Eyes
Test 8.5BCLens Power Requirement-2.75 to -2.2517 Eyes
Test 9.0BCLens Power Requirement-2.75 to -2.2515 Eyes
Test 9.0BCLens Power Requirement-2.00 t -1.5010 Eyes
Test 9.0BCLens Power Requirement-1.25 to -0.752 Eyes
Test 9.0BCLens Power Requirement-3.50 to -3.009 Eyes
Test 9.0BCLens Power Requirement<= -3.759 Eyes
Test 9.0BCLens Power Requirement>= -0.503 Eyes
Control 8.5BCLens Power Requirement-3.50 to -3.007 Eyes
Control 8.5BCLens Power Requirement<= -3.7510 Eyes
Control 8.5BCLens Power Requirement-2.75 to -2.2516 Eyes
Control 8.5BCLens Power Requirement-2.00 t -1.5010 Eyes
Control 8.5BCLens Power Requirement-1.25 to -0.753 Eyes
Control 8.5BCLens Power Requirement>= -0.502 Eyes
Control 9.0BCLens Power Requirement>= -0.503 Eyes
Control 9.0BCLens Power Requirement-1.25 to -0.752 Eyes
Control 9.0BCLens Power Requirement<= -3.758 Eyes
Control 9.0BCLens Power Requirement-3.50 to -3.0010 Eyes
Control 9.0BCLens Power Requirement-2.00 t -1.5010 Eyes
Control 9.0BCLens Power Requirement-2.75 to -2.2515 Eyes
97.5% CI: [81.1, 98.1]Wilson Method
97.5% CI: [68.3, 92.1]Wilson Method
97.5% CI: [90.5, 100]Wilson Method
97.5% CI: [90.5, 100]Wilson Method
Primary

Overall Fit Acceptance

Overall lens fit acceptance was assessed by the investigator based on lens fitting characteristics and graded on a scale of 0 to 5, where 0=should not be worn and 5=perfect fit. The score ranges from 0 to 5, where higher scores indicate better fitting. The number of eye for each Grade was reported.

Time frame: 30-45 minutes after lens settling

Population: All subjects who had successfully completed all required assessments visits without any a major protocol deviations.

ArmMeasureCategoryValue (COUNT_OF_UNITS)
Test 8.5BCOverall Fit Acceptance00 Eyes
Test 8.5BCOverall Fit Acceptance10 Eyes
Test 8.5BCOverall Fit Acceptance21 Eyes
Test 8.5BCOverall Fit Acceptance35 Eyes
Test 8.5BCOverall Fit Acceptance417 Eyes
Test 8.5BCOverall Fit Acceptance525 Eyes
Test 9.0BCOverall Fit Acceptance514 Eyes
Test 9.0BCOverall Fit Acceptance38 Eyes
Test 9.0BCOverall Fit Acceptance00 Eyes
Test 9.0BCOverall Fit Acceptance22 Eyes
Test 9.0BCOverall Fit Acceptance10 Eyes
Test 9.0BCOverall Fit Acceptance424 Eyes
Control 8.5BCOverall Fit Acceptance10 Eyes
Control 8.5BCOverall Fit Acceptance21 Eyes
Control 8.5BCOverall Fit Acceptance35 Eyes
Control 8.5BCOverall Fit Acceptance523 Eyes
Control 8.5BCOverall Fit Acceptance419 Eyes
Control 8.5BCOverall Fit Acceptance00 Eyes
Control 9.0BCOverall Fit Acceptance417 Eyes
Control 9.0BCOverall Fit Acceptance519 Eyes
Control 9.0BCOverall Fit Acceptance10 Eyes
Control 9.0BCOverall Fit Acceptance37 Eyes
Control 9.0BCOverall Fit Acceptance00 Eyes
Control 9.0BCOverall Fit Acceptance25 Eyes
95% CI: [0.46, 3.06]Generalized linear mixed model
95% CI: [0.34, 2.52]Generalized linear mixed model
Secondary

Monocular High Contrast Visual Acuity (VA)

Monocular high contrast distance VA with the study lenses was collected to the nearest letter using computer generated logMAR charts. 0.02 logMAR is equivalent to 1 letter. Negative logMAR values indicate better lens performance. The average visual acuity was reported for each lens type.

Time frame: 30-45 minutes after lens settling

Population: All subjects who had successfully completed all required assessments without a major protocol deviation.

ArmMeasureValue (MEAN)Dispersion
Test 8.5BCMonocular High Contrast Visual Acuity (VA)-0.02 logMARStandard Deviation 0.068
Test 9.0BCMonocular High Contrast Visual Acuity (VA)-0.02 logMARStandard Deviation 0.083
Control 8.5BCMonocular High Contrast Visual Acuity (VA)-0.02 logMARStandard Deviation 0.064
Control 9.0BCMonocular High Contrast Visual Acuity (VA)-0.02 logMARStandard Deviation 0.061
95% CI: [-0.009, 0.012]Linear mixed model
95% CI: [-0.012, 0.009]Linear mixed model
Secondary

Subjective Comfort After Lens Settling

Subjective comfort on setting was assessed by the subject on an 11-point scale (0 to 10) where 0=painful and 10=can't be felt. The score ranges from 0 to 10, where higher scores indicate better comfort. The average comfort score for each lens was reported.

Time frame: 30-45 minutes after lens settling

Population: All subjects who had successfully completed all required assessments without a major protocol deviation.

ArmMeasureValue (MEAN)Dispersion
Test 8.5BCSubjective Comfort After Lens Settling9.50 Graded scale 0-10Standard Deviation 0.715
Test 9.0BCSubjective Comfort After Lens Settling9.27 Graded scale 0-10Standard Deviation 1.005
Control 8.5BCSubjective Comfort After Lens Settling9.56 Graded scale 0-10Standard Deviation 0.769
Control 9.0BCSubjective Comfort After Lens Settling9.13 Graded scale 0-10Standard Deviation 1.214
95% CI: [-0.4, 0.3]Linear mixed model
95% CI: [-0.2, 0.5]Linear mixed model
Secondary

Subjective Comfort at Lens Insertion

Subjective comfort on insertion was assessed by the subject on an 11-point scale (0 to 10) where 0=painful and 10=can't be felt. The score ranges from 0 to 10, where higher scores indicate better comfort. The average comfort score for each lens was reported.

Time frame: Immediately upon lens insertion

Population: All subjects who had successfully completed all required assessments without a major protocol deviation.

ArmMeasureValue (MEAN)Dispersion
Test 8.5BCSubjective Comfort at Lens Insertion9.15 Graded Scale 0-10Standard Deviation 1.353
Test 9.0BCSubjective Comfort at Lens Insertion9.04 Graded Scale 0-10Standard Deviation 1.22
Control 8.5BCSubjective Comfort at Lens Insertion8.92 Graded Scale 0-10Standard Deviation 1.302
Control 9.0BCSubjective Comfort at Lens Insertion9.02 Graded Scale 0-10Standard Deviation 1.176
95% CI: [-0.3, 0.7]Linear mixed model
95% CI: [-0.5, 0.5]Linear mixed model
Secondary

Subjective Handling

Subjective handling was assessed by the subject on an 11-point scale (0 to 10) where 0=extremely difficult and 10=very easy. The score ranges from 0 to 10, where higher scores indicate better handling. The average handling score for each lens was reported.

Time frame: Immediately upon lens insertion

Population: All subjects who had successfully completed all required assessments without a major protocol deviation.

ArmMeasureValue (MEAN)Dispersion
Test 8.5BCSubjective Handling9.17 Graded scale 0-10Standard Deviation 1.243
Test 9.0BCSubjective Handling9.10 Graded scale 0-10Standard Deviation 1.242
Control 8.5BCSubjective Handling9.13 Graded scale 0-10Standard Deviation 1.248
Control 9.0BCSubjective Handling9.25 Graded scale 0-10Standard Deviation 1.139
95% CI: [-0.5, 0.5]Linear mixed model
95% CI: [-0.6, 0.4]Linear mixed model
Secondary

Subjective Vision Quality

Subjective vision quality was assessed by the subject on an 11-point scale (0 to 10) where 0=extremely blurred and 10=perfect. The score ranges from 0 to 10, where higher scores indicate better vision quality. The average vision quality score for each lens was reported.

Time frame: 30-45 minutes after lens settling

Population: All subjects who had successfully completed all required assessments without a major protocol deviation.

ArmMeasureValue (MEAN)Dispersion
Test 8.5BCSubjective Vision Quality9.33 Graded scale 0-10Standard Deviation 0.753
Test 9.0BCSubjective Vision Quality9.25 Graded scale 0-10Standard Deviation 0.911
Control 8.5BCSubjective Vision Quality9.19 Graded scale 0-10Standard Deviation 1.104
Control 9.0BCSubjective Vision Quality9.19 Graded scale 0-10Standard Deviation 1.065
95% CI: [-0.1, 0.4]Linear mixed model
95% CI: [-0.2, 0.3]Linear mixed model

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026